| |
About QuantRx® Biomedical
QuantRx Biomedical Corporation is an emerging leader in the development of products for advanced diagnosis of serious disease and health conditions. With synergistic expertise in the discovery of diagnostic platforms and the commercialization of products for use by medical professionals, institutions, and consumers, QuantRx is focused on providing more accurate, reliable, and faster diagnoses that result in improved patient care.The QuantRx strategy is one of sustained growth and targets significant market opportunities estimated to be in excess of $4 billion worldwide.
|
|
|
QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader™) at MEDICA 2009, the World’s Leading Medical Trade Fair
Company Schedules Annual Shareholder Meeting for December 3, 2009
QuantRx® Forms Joint Venture with NuRx for the Global Launch of Innovative Point-of-Care Products
|
|
|
